What Is the Hand, Foot, and Mouth Disease Age Range?

Hand, foot, and mouth disease (HFMD) overwhelmingly strikes children under five, with the sharpest peak between ages one and two. But the virus does not check IDs at the door. Adults can and do catch it, and certain viral strains have pushed the age range upward in recent years. The real story behind who gets HFMD, and why, involves the interplay of waning maternal protection, immune naivety in toddlers, and shifting viral serotypes that occasionally blindside older age groups.

The Peak Age and Why It Matters

Large surveillance studies consistently pin the highest HFMD rates on very young children. A nationwide analysis of cases in South Korea from 2011 to 2017 found that children younger than four accounted for the bulk of infections, with one-year-olds making up about 39% of all cases and two-year-olds another 26%. Altogether, roughly 93% of cases occurred before the age of six.¹ A study from Guangzhou, China, found a nearly identical pattern, with about 91% of cases occurring in children under five.²

The reasons are straightforward. Young children have immature immune systems that have not yet built up antibodies against the enteroviruses responsible for HFMD. They also congregate in daycare centers and preschools, where the virus spreads easily through direct contact and contaminated surfaces.³ A modeling study in Vietnam confirmed that the force of infection peaks at one to two years of age, meaning children in that narrow window are most likely to encounter the virus for the first time.⁴

Why Very Young Infants Are Partially Shielded

You might expect newborns to be the most vulnerable, but infants in their first few weeks of life actually carry some protection borrowed from their mothers. Antibodies cross the placenta during pregnancy, and a longitudinal study of Chinese mother-infant pairs measured an average transfer ratio of 0.88 for coxsackievirus A16 antibodies. Those transferred antibodies fade fast, though, with a half-life of about two months. By around six weeks of age, antibody levels in the average infant drop below the threshold considered protective.⁵

Mothers with higher antibody levels at delivery gave their babies a longer head start. When a mother’s titer was at or above 64, her infant maintained protective antibody levels for an average of about six months rather than the typical three.⁵ This window helps explain the epidemiological gap: very young infants are somewhat shielded, but once maternal antibodies vanish and the child starts spending time around other kids, susceptibility climbs steeply.

When Age Drives Severity

HFMD is usually mild at any age, resolving in a week or so with fever, mouth sores, and a rash on the hands and feet. But when complications happen, the youngest children bear the brunt. A study examining enterovirus 71 infections found that children under two faced significantly greater odds of severe disease compared with older kids. The risk of delayed recognition of critical infection was nearly ten times higher in that youngest group, and the odds of progressing to cardiopulmonary failure were about eight times higher.⁶

Neonatal cases are rare but can be alarming. Case reports describe newborns developing brainstem encephalitis and pulmonary edema from HFMD, complications that require intensive care.⁷ These extreme outcomes are unusual enough to be published as individual case reports, which gives a sense of how uncommon they are, but they underscore why pediatricians watch infants with HFMD more closely than they do a four-year-old with the same infection.

Enterovirus 71 in particular is the serotype most strongly linked to neurological complications such as meningitis, encephalitis, and acute flaccid paralysis. When public health officials track HFMD fatalities, those deaths cluster among children under five.² Older children and adults who catch the same virus almost never develop these serious consequences, likely because their immune systems mount a faster, more organized response.

Adults Get HFMD Too

One of the most persistent misconceptions is that HFMD is exclusively a childhood illness. It is not. Adults catch it, and in some outbreak settings they account for a meaningful share of cases. During outbreaks tied to coxsackievirus A6 reported to the CDC between late 2011 and early 2012, roughly a quarter of the confirmed cases were adults, most of whom had been in contact with infected children.⁸ CVA6 continues to be linked to adult cases more frequently than the classic HFMD serotypes, often presenting with more extensive skin involvement and, in some instances, nail shedding weeks after the infection.⁹

A multicenter study conducted during the COVID-19 pandemic noted an unusually high proportion of adult HFMD cases compared with pre-pandemic baselines, with subtle differences in how the rash appeared in adults versus children.¹⁰ Whether this reflected a real shift in viral epidemiology or changes in healthcare-seeking behavior during lockdowns is still debated, but the finding reinforced that adults are not immune to the virus.

Parents of young children are the adults most commonly affected, for the obvious reason that they are changing diapers, wiping noses, and sharing cups with the small people who carry the highest viral loads. But adult HFMD is not limited to parents. A documented outbreak among college students at a U.S. university found an average case age of 19.2 years. The majority of affected students lived in on-campus housing, and clusters appeared among students who played club or varsity sports together.¹¹ Shared bathrooms, kitchens, and athletic facilities created conditions that mimicked the daycare dynamics usually seen in younger age groups.

How Immunity Builds Through Childhood

The reason HFMD fades as a concern for most people after early childhood is that repeated exposure to enteroviruses builds up a wall of antibodies over time. But “the enteroviruses” is not one virus. HFMD is caused by more than a dozen different serotypes, and catching one does not protect you against the others. This is a key part of why children can get HFMD more than once, and why an adult might catch a strain they never encountered as a kid.

Seroprevalence studies paint a picture of gradually accumulating immunity. In Vietnam, antibodies against coxsackievirus A6 and A10 reached about 90% among children aged six to seven, suggesting that nearly all kids had been exposed to those strains by early school age. Coxsackievirus A16 and enterovirus 71, by contrast, showed seroprevalence of only around 50% in the same age group, meaning a substantial fraction of children remained susceptible.⁴ A German study found an even starker gap in younger children: among one-to-four-year-olds, only about 12% had antibodies to enterovirus 71 and 27% to coxsackievirus A16, leaving the vast majority unprotected against those strains.¹²

By the time children reach the ten-to-fourteen age range, antibody levels tend to be high across multiple serotypes.¹² This accumulated immunity is the main reason teenagers and adults rarely get HFMD. It is not that older people are inherently resistant; it is that most of them were already infected, often without symptoms, during the years of heaviest exposure. When a new serotype circulates widely or an individual somehow missed the usual childhood encounters, the door is open regardless of age.

Eczema and Atypical Presentations

Children with eczema (atopic dermatitis) deserve a separate mention because they can develop a much more dramatic version of the disease called eczema coxsackium. Instead of the small, scattered blisters typical of HFMD, these children break out in widespread vesicular and erosive eruptions that concentrate on areas of eczematous skin, whether the eczema is currently flaring or not. The rash can involve the mouth, spread beyond the usual hands-feet-buttocks distribution, and look severe enough to prompt emergency visits.¹³

Eczema coxsackium is most commonly triggered by the same CVA6 and CVA16 strains responsible for standard HFMD. Because eczema itself is most common in young children, this overlap means toddlers with pre-existing skin conditions face a double vulnerability: they are at peak age for HFMD exposure and their disrupted skin barrier allows the virus to cause more extensive damage. If your child has eczema and a daycare classmate comes down with HFMD, the rash your child develops may look nothing like the mild, textbook version, and that disconnect catches many parents off guard.

The CVA6 Factor in Expanding the Age Range

Classic HFMD caused by enterovirus 71 or coxsackievirus A16 follows a tidy epidemiological pattern: toddlers get it, older kids mostly don’t, adults almost never do. Coxsackievirus A6 has muddied that picture. Since 2004, CVA6 has caused outbreaks across Asia, Europe, and North America that included a higher-than-usual proportion of older children and adults.⁸ The presentations tend to be more severe than typical HFMD: higher fevers, more widespread skin eruptions, and more hospitalizations for pain and dehydration.

One reason CVA6 reaches beyond the usual age range is that many adults and older children simply never encountered it during the years when it circulated less commonly. Their childhood immunity, built against CVA16 or enterovirus 71, does not cross-protect against CVA6. When CVA6 surges through a community, it effectively resets the susceptibility clock for people who assumed they had “already had” HFMD. This serotype-specific gap in immunity is also why vaccine development has been so complicated. The inactivated enterovirus 71 vaccines licensed in China have proven effective against EV-A71 disease, but they do not protect against CVA16 or other HFMD-causing serotypes.¹⁴ A multivalent vaccine covering the major serotypes remains a research goal, not a clinical reality.

Practical Takeaways for Different Age Groups

For parents of children between about six months and five years, HFMD is essentially an expected part of childhood. Most cases are mild and resolve on their own. The main job is symptom management: keeping the child hydrated (mouth sores can make drinking painful), controlling fever with standard over-the-counter medications, and keeping them out of daycare until the fever breaks and the blisters begin to crust over. Watch children under two more carefully for signs of lethargy, persistent vomiting, or unusual sleepiness, which could signal a more serious enteroviral infection.⁶

For adults who catch it from their kids, the reassurance is that serious complications are exceedingly rare. The annoyance, however, can be real. Adult HFMD sometimes produces more painful mouth sores and foot blisters than the childhood version, and nail shedding a few weeks later (onychomadesis) is unsettling even though it is temporary and the nails grow back normally. If you are pregnant and exposed, it is worth mentioning to your OB, as neonatal enterovirus infections are uncommon but can be severe.

For college students or military recruits living in close quarters, outbreaks are rare but not unheard of. Shared bathrooms and communal living spaces create transmission dynamics similar to daycare. Basic hand hygiene and disinfecting shared surfaces are the same preventive measures that apply at any age.

Why HFMD Keeps Coming Back

Parents sometimes wonder why their child can get HFMD twice, or even three times, in a single year. The answer lies in serotype diversity. More than a dozen enteroviruses cause HFMD, and immunity to one does not guarantee immunity to another. A child who recovers from a CVA16 infection in March has strong, lasting protection against future CVA16 infections but remains fully susceptible to CVA6, EV-A71, or any of the other circulating strains. Seroprevalence data from Guangdong, China showed that children under three, particularly two-year-olds, had the lowest pre-epidemic antibody rates for both EV71 and CVA16, and that rates jumped significantly after an epidemic swept through.¹⁵ Each wave of infection essentially vaccinates the population against that particular strain, but the next strain in line finds plenty of susceptible hosts.

This rolling pattern of exposure and partial immunity is why HFMD does not behave like chickenpox, where a single infection confers broad, lasting protection. It is closer to how colds work: you build immunity to the specific virus you caught, but there is always another one you haven’t seen yet. For most children, the practical result is two or three bouts of HFMD during the toddler and preschool years, each caused by a different serotype, followed by enough cumulative immunity that the disease becomes rare by school age. The Vietnamese seroprevalence data showing 90% antibody positivity for CVA6 and CVA10 by ages six to seven reflects this pattern of repeated natural exposure doing what no single infection can.⁴

1
PubMed Central. The epidemiological characteristics and spatio-temporal analysis of childhood hand, foot and mouth disease in Korea, 2011-2017
2
PubMed Central. Influence of temperature and humidity on hand, foot, and mouth disease in Guangzhou, 2013–2017
3
PubMed Central. Molecular Epidemiological Study of Hand, Foot, and Mouth Disease in a Kindergarten-Based Setting in Bangkok, Thailand
4
PubMed Central. Age-time-specific transmission of hand-foot-and-mouth disease enterovirus serotypes in Vietnam: A catalytic model with maternal immunity
5
PubMed Central. The transfer of maternal antibodies and dynamics of maternal and natural infection-induced antibodies against coxsackievirus A16 in Chinese children 0–13 years of age: a longitudinal cohort study
6
PubMed. Predicting severe enterovirus 71 infection: Age, comorbidity, and parental behavior matter
7
PubMed Central. A neonate with hand, foot, and mouth disease complicated with brainstem encephalitis and pulmonary edema: A complete recovery
8
JAMA Dermatology. Coxsackievirus A6–Induced Hand-Foot-Mouth Disease
9
PubMed Central. Onychomadesis: A Rare Manifestation of Coxsackievirus A6 Infection in an Adult Patient
10
PubMed Central. Hand Foot Mouth Disease During the SARS-CoV-2 Pandemic: A Multicentric Study
11
Journal of Primary Care & Community Health. A Hand-Foot-and-Mouth Disease Outbreak in an Atypical Population of College Students
12
PubMed. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany
13
PubMed. Eczema Coxsackium: An Unusual Presentation in Atopic Dermatitis and Hand, Foot, and Mouth Disease
14
PubMed Central. Is a multivalent hand, foot, and mouth disease vaccine feasible?
15
PubMed Central. Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period